Switch to:
Also traded in: Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.51
SYK's Cash-to-Debt is ranked lower than
76% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.87 vs. SYK: 0.51 )
Ranked among companies with meaningful Cash-to-Debt only.
SYK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 1.81 Max: 164.16
Current: 0.51
0.04
164.16
Equity-to-Asset 0.47
SYK's Equity-to-Asset is ranked lower than
73% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SYK: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
SYK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.65 Max: 0.78
Current: 0.47
0.22
0.78
Debt-to-Equity 0.73
SYK's Debt-to-Equity is ranked lower than
81% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 0.27 vs. SYK: 0.73 )
Ranked among companies with meaningful Debt-to-Equity only.
SYK' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.14 Max: 2.52
Current: 0.73
0
2.52
Debt-to-EBITDA 2.62
SYK's Debt-to-EBITDA is ranked lower than
62% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SYK: 2.62 )
Ranked among companies with meaningful Debt-to-EBITDA only.
SYK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01  Med: 0.88 Max: 2.62
Current: 2.62
0.01
2.62
Interest Coverage N/A
SYK's Interest Coverage is ranked higher than
74% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 71.12 vs. SYK: N/A )
Ranked among companies with meaningful Interest Coverage only.
SYK' s Interest Coverage Range Over the Past 10 Years
Min: 24.66  Med: 37.57 Max: No Debt
Current: N/A
Piotroski F-Score: 5
Altman Z-Score: 4.74
Beneish M-Score: -2.39
WACC vs ROIC
5.03%
14.40%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 18.42
SYK's Operating Margin % is ranked higher than
87% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. SYK: 18.42 )
Ranked among companies with meaningful Operating Margin % only.
SYK' s Operating Margin % Range Over the Past 10 Years
Min: 12.88  Med: 20.21 Max: 23.92
Current: 18.42
12.88
23.92
Net Margin % 14.22
SYK's Net Margin % is ranked higher than
84% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. SYK: 14.22 )
Ranked among companies with meaningful Net Margin % only.
SYK' s Net Margin % Range Over the Past 10 Years
Min: 5.32  Med: 15.59 Max: 17.39
Current: 14.22
5.32
17.39
ROE % 17.81
SYK's ROE % is ranked higher than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. SYK: 17.81 )
Ranked among companies with meaningful ROE % only.
SYK' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 18.18 Max: 21.28
Current: 17.81
5.84
21.28
ROA % 8.26
SYK's ROA % is ranked higher than
82% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.11 vs. SYK: 8.26 )
Ranked among companies with meaningful ROA % only.
SYK' s ROA % Range Over the Past 10 Years
Min: 3.12  Med: 10.96 Max: 15.38
Current: 8.26
3.12
15.38
ROC (Joel Greenblatt) % 66.82
SYK's ROC (Joel Greenblatt) % is ranked higher than
90% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.41 vs. SYK: 66.82 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SYK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 43.65  Med: 67.67 Max: 108.61
Current: 66.82
43.65
108.61
3-Year Revenue Growth Rate 8.20
SYK's 3-Year Revenue Growth Rate is ranked higher than
61% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. SYK: 8.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SYK' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.9  Med: 13.5 Max: 32.9
Current: 8.2
4.9
32.9
3-Year EBITDA Growth Rate 20.50
SYK's 3-Year EBITDA Growth Rate is ranked higher than
68% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. SYK: 20.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SYK' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.6  Med: 16.8 Max: 59.8
Current: 20.5
-9.6
59.8
3-Year EPS without NRI Growth Rate 18.30
SYK's 3-Year EPS without NRI Growth Rate is ranked higher than
69% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SYK: 18.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SYK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -42.6  Med: 19.8 Max: 153
Current: 18.3
-42.6
153
GuruFocus has detected 7 Warning Signs with Stryker Corp SYK.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SYK's 30-Y Financials

Financials (Next Earnings Date: 2017-10-26)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

SYK Guru Trades in Q4 2016

Steven Cohen 337,600 sh (New)
Pioneer Investments 45,949 sh (+9.24%)
Diamond Hill Capital 919,621 sh (+9.01%)
Jeremy Grantham 1,470,782 sh (+6.13%)
Murray Stahl 2,000 sh (unchged)
PRIMECAP Management 228,400 sh (unchged)
Paul Tudor Jones Sold Out
Donald Yacktman 1,140,765 sh (-9.77%)
Yacktman Fund 900,000 sh (-10.00%)
Robert Olstein 28,500 sh (-10.94%)
Vanguard Health Care Fund 1,654,500 sh (-23.39%)
» More
Q1 2017

SYK Guru Trades in Q1 2017

Joel Greenblatt 57,072 sh (New)
Jim Simons 7,200 sh (New)
Caxton Associates 4,600 sh (New)
Pioneer Investments 58,469 sh (+27.25%)
Vanguard Health Care Fund 1,654,500 sh (unchged)
Murray Stahl 2,000 sh (unchged)
PRIMECAP Management 228,400 sh (unchged)
Louis Moore Bacon Sold Out
Diamond Hill Capital 898,655 sh (-2.28%)
Jeremy Grantham 1,150,968 sh (-21.74%)
Donald Yacktman 800,461 sh (-29.83%)
Robert Olstein 19,000 sh (-33.33%)
Yacktman Fund 600,000 sh (-33.33%)
Steven Cohen 176,800 sh (-47.63%)
» More
Q2 2017

SYK Guru Trades in Q2 2017

Mario Gabelli 2,600 sh (New)
David Tepper 445,000 sh (New)
Jim Simons 32,300 sh (+348.61%)
Jeremy Grantham 1,167,721 sh (+1.46%)
Vanguard Health Care Fund 1,654,500 sh (unchged)
Murray Stahl 2,000 sh (unchged)
Robert Olstein Sold Out
Caxton Associates Sold Out
Joel Greenblatt Sold Out
PRIMECAP Management 227,500 sh (-0.39%)
Yacktman Fund 550,000 sh (-8.33%)
Donald Yacktman 717,491 sh (-10.37%)
Diamond Hill Capital 802,494 sh (-10.70%)
Steven Cohen 151,100 sh (-14.54%)
Pioneer Investments 39,287 sh (-32.81%)
» More
Q3 2017

SYK Guru Trades in Q3 2017

Yacktman Fund 550,000 sh (unchged)
Diamond Hill Capital Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Donald Yacktman 2017-06-30 Reduce -10.37%0.1%$129.93 - $144.7 $ 150.4910%717,491
Yacktman Fund 2017-06-30 Reduce -8.33%0.1%$129.93 - $144.7 $ 150.4910%550,000
David Tepper 2017-06-30 New Buy0.92%$129.93 - $144.7 $ 150.4910%445,000
Mario Gabelli 2017-06-30 New Buy$129.93 - $144.7 $ 150.4910%2,600
Joel Greenblatt 2017-06-30 Sold Out 0.1%$129.93 - $144.7 $ 150.4910%0
Robert Olstein 2017-06-30 Sold Out 0.32%$129.93 - $144.7 $ 150.4910%0
Donald Yacktman 2017-03-31 Reduce -29.83%0.37%$117.75 - $132.83 $ 150.4919%800,461
Yacktman Fund 2017-03-31 Reduce -33.33%0.54%$117.75 - $132.83 $ 150.4919%600,000
Joel Greenblatt 2017-03-31 New Buy0.1%$117.75 - $132.83 $ 150.4919%57,072
Robert Olstein 2017-03-31 Reduce -33.33%0.15%$117.75 - $132.83 $ 150.4919%19,000
Vanguard Health Care Fund 2016-12-31 Reduce -23.39%0.13%$106.68 - $120.85 $ 150.4931%1,654,500
Donald Yacktman 2016-12-31 Reduce -9.77%0.13%$106.68 - $120.85 $ 150.4931%1,140,765
Yacktman Fund 2016-12-31 Reduce -10.00%0.17%$106.68 - $120.85 $ 150.4931%900,000
Robert Olstein 2016-12-31 Reduce -10.94%0.05%$106.68 - $120.85 $ 150.4931%28,500
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NYSE:BSX, NAS:ISRG, NYSE:ZBH, NYSE:EW, LSE:SN., NYSE:ABT, NAS:ALGN, XSWX:SOON, NYSE:TFX, NYSE:VAR, ASX:COH, NAS:ABMD, LSE:CTEC, OCSE:WDH, XPAR:DIM, SZSE:300003, NZSE:FPH, OCSE:GN, NAS:MASI, OSTO:EKTA B » details
Traded in other countries:SYK.Germany, SYK.Mexico, SYK.Switzerland, 0R2S.UK,
Headquarter Location:USA
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.

Stryker designs, manufactures, and markets an array of medical equipment, instruments, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.

Ratios

vs
industry
vs
history
PE Ratio 33.59
SYK's PE Ratio is ranked lower than
53% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 30.77 vs. SYK: 33.59 )
Ranked among companies with meaningful PE Ratio only.
SYK' s PE Ratio Range Over the Past 10 Years
Min: 11.3  Med: 24.87 Max: 71.37
Current: 33.59
11.3
71.37
Forward PE Ratio 21.23
SYK's Forward PE Ratio is ranked higher than
78% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. SYK: 21.23 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 33.59
SYK's PE Ratio without NRI is ranked lower than
55% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.81 vs. SYK: 33.59 )
Ranked among companies with meaningful PE Ratio without NRI only.
SYK' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.3  Med: 25.09 Max: 71.37
Current: 33.59
11.3
71.37
Price-to-Owner-Earnings 41.12
SYK's Price-to-Owner-Earnings is ranked lower than
52% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 37.10 vs. SYK: 41.12 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SYK' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.61  Med: 25.82 Max: 187.7
Current: 41.12
12.61
187.7
PB Ratio 5.59
SYK's PB Ratio is ranked lower than
72% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. SYK: 5.59 )
Ranked among companies with meaningful PB Ratio only.
SYK' s PB Ratio Range Over the Past 10 Years
Min: 2.19  Med: 3.41 Max: 6.24
Current: 5.59
2.19
6.24
PS Ratio 4.77
SYK's PS Ratio is ranked lower than
64% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. SYK: 4.77 )
Ranked among companies with meaningful PS Ratio only.
SYK' s PS Ratio Range Over the Past 10 Years
Min: 1.93  Med: 3.34 Max: 5.29
Current: 4.77
1.93
5.29
Price-to-Free-Cash-Flow 43.01
SYK's Price-to-Free-Cash-Flow is ranked lower than
65% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 28.08 vs. SYK: 43.01 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SYK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.66  Med: 19.88 Max: 95.2
Current: 43.01
11.66
95.2
Price-to-Operating-Cash-Flow 30.73
SYK's Price-to-Operating-Cash-Flow is ranked lower than
67% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. SYK: 30.73 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SYK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.23  Med: 17.05 Max: 54.05
Current: 30.73
10.23
54.05
EV-to-EBIT 27.21
SYK's EV-to-EBIT is ranked lower than
55% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 23.37 vs. SYK: 27.21 )
Ranked among companies with meaningful EV-to-EBIT only.
SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 15.2 Max: 35.3
Current: 27.21
6.8
35.3
EV-to-EBITDA 21.31
SYK's EV-to-EBITDA is ranked lower than
56% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 17.75 vs. SYK: 21.31 )
Ranked among companies with meaningful EV-to-EBITDA only.
SYK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.5 Max: 25.6
Current: 21.31
5.5
25.6
EV-to-Revenue 5.01
SYK's EV-to-Revenue is ranked lower than
63% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. SYK: 5.01 )
Ranked among companies with meaningful EV-to-Revenue only.
SYK' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5  Med: 3.2 Max: 5
Current: 5.01
1.5
5
PEG Ratio 5.33
SYK's PEG Ratio is ranked lower than
73% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. SYK: 5.33 )
Ranked among companies with meaningful PEG Ratio only.
SYK' s PEG Ratio Range Over the Past 10 Years
Min: 0.51  Med: 1.82 Max: 76.24
Current: 5.33
0.51
76.24
Shiller PE Ratio 44.94
SYK's Shiller PE Ratio is ranked higher than
58% of the 52 Companies
in the Global Medical Devices industry.

( Industry Median: 50.47 vs. SYK: 44.94 )
Ranked among companies with meaningful Shiller PE Ratio only.
SYK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.27  Med: 30.79 Max: 71.26
Current: 44.94
20.27
71.26
Current Ratio 2.39
SYK's Current Ratio is ranked lower than
55% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. SYK: 2.39 )
Ranked among companies with meaningful Current Ratio only.
SYK' s Current Ratio Range Over the Past 10 Years
Min: 1.61  Med: 2.9 Max: 5.37
Current: 2.39
1.61
5.37
Quick Ratio 1.75
SYK's Quick Ratio is ranked lower than
54% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SYK: 1.75 )
Ranked among companies with meaningful Quick Ratio only.
SYK' s Quick Ratio Range Over the Past 10 Years
Min: 0.98  Med: 2.06 Max: 4.63
Current: 1.75
0.98
4.63
Days Inventory 190.57
SYK's Days Inventory is ranked lower than
69% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 139.39 vs. SYK: 190.57 )
Ranked among companies with meaningful Days Inventory only.
SYK' s Days Inventory Range Over the Past 10 Years
Min: 144.2  Med: 161.51 Max: 190.57
Current: 190.57
144.2
190.57
Days Sales Outstanding 58.15
SYK's Days Sales Outstanding is ranked higher than
67% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 67.97 vs. SYK: 58.15 )
Ranked among companies with meaningful Days Sales Outstanding only.
SYK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.15  Med: 61.84 Max: 63.4
Current: 58.15
58.15
63.4
Days Payable 38.52
SYK's Days Payable is ranked lower than
72% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. SYK: 38.52 )
Ranked among companies with meaningful Days Payable only.
SYK' s Days Payable Range Over the Past 10 Years
Min: 33.46  Med: 43.2 Max: 51.96
Current: 38.52
33.46
51.96

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.13
SYK's Dividend Yield % is ranked lower than
52% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 1.38 vs. SYK: 1.13 )
Ranked among companies with meaningful Dividend Yield % only.
SYK' s Dividend Yield % Range Over the Past 10 Years
Min: 0.27  Med: 1.27 Max: 1.66
Current: 1.13
0.27
1.66
Dividend Payout Ratio 0.37
SYK's Dividend Payout Ratio is ranked lower than
52% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 0.36 vs. SYK: 0.37 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SYK' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.24 Max: 0.94
Current: 0.37
0.05
0.94
3-Year Dividend Growth Rate 12.50
SYK's 3-Year Dividend Growth Rate is ranked higher than
57% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 10.90 vs. SYK: 12.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SYK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 20.4 Max: 81.9
Current: 12.5
0
81.9
Forward Dividend Yield % 1.13
SYK's Forward Dividend Yield % is ranked lower than
60% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SYK: 1.13 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.35
SYK's 5-Year Yield-on-Cost % is ranked higher than
69% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. SYK: 2.35 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SYK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.56  Med: 2.64 Max: 3.46
Current: 2.35
0.56
3.46
3-Year Average Share Buyback Ratio 0.30
SYK's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. SYK: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SYK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.8  Med: -0.2 Max: 1.9
Current: 0.3
-0.8
1.9

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 308.38
SYK's Price-to-Tangible-Book is ranked lower than
99% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. SYK: 308.38 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SYK' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.87  Med: 5.97 Max: 665.79
Current: 308.38
2.87
665.79
Price-to-Intrinsic-Value-Projected-FCF 2.36
SYK's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
52% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. SYK: 2.36 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SYK' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.92  Med: 2.13 Max: 112.27
Current: 2.36
0.92
112.27
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.14
SYK's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
70% of the 27 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SYK: 3.14 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
SYK' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.43  Med: 1.09 Max: 25.6
Current: 3.14
0.43
25.6
Price-to-Median-PS-Value 1.43
SYK's Price-to-Median-PS-Value is ranked lower than
68% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. SYK: 1.43 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SYK' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53  Med: 1.04 Max: 1.89
Current: 1.43
0.53
1.89
Price-to-Peter-Lynch-Fair-Value 3.12
SYK's Price-to-Peter-Lynch-Fair-Value is ranked lower than
75% of the 51 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. SYK: 3.12 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SYK' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.55  Med: 1.58 Max: 34.14
Current: 3.12
0.55
34.14
Price-to-Graham-Number 21.47
SYK's Price-to-Graham-Number is ranked lower than
98% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. SYK: 21.47 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SYK' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.25  Med: 2.68 Max: 36.67
Current: 21.47
1.25
36.67
Earnings Yield (Greenblatt) % 3.68
SYK's Earnings Yield (Greenblatt) % is ranked higher than
71% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.94 vs. SYK: 3.68 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SYK' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 6.6 Max: 14.6
Current: 3.68
2.8
14.6
Forward Rate of Return (Yacktman) % 13.14
SYK's Forward Rate of Return (Yacktman) % is ranked higher than
63% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 6.44 vs. SYK: 13.14 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SYK' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.8  Med: 10.7 Max: 28.8
Current: 13.14
-3.8
28.8

More Statistics

Revenue (TTM) (Mil) $11,957.00
EPS (TTM) $ 4.48
Beta0.53
Short Percentage of Float1.50%
52-Week Range $106.48 - 150.51
Shares Outstanding (Mil)374.06

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 12,265 13,066 13,837 14,477
EPS ($) 6.41 7.10 7.82 8.53
EPS without NRI ($) 6.41 7.10 7.82 8.53
EPS Growth Rate
(Future 3Y To 5Y Estimate)
8.99%
Dividends per Share ($) 1.50 1.59 2.12

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}